Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/11801
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Personalised cancer follow-up: risk stratification, needs assessment or both?
Authors: Watson, Eila
Rose, Peter W
Neal, Richard D
Hulbert-Williams, Nick
Donnelly, Peter K
Hubbard, Gill
Elliott, James
Campbell, Christine
Weller, David
Wilkinson, Clare
Contact Email: gill.hubbard@stir.ac.uk
Issue Date: 3-Jan-2012
Publisher: Nature Publishing Group
Citation: Watson E, Rose PW, Neal RD, Hulbert-Williams N, Donnelly PK, Hubbard G, Elliott J, Campbell C, Weller D & Wilkinson C (2012) Personalised cancer follow-up: risk stratification, needs assessment or both?, British Journal of Cancer, 106 (1), pp. 1-5.
Abstract: First paragraph: There are approximately 2 million people now living with or beyond cancer in the UK (Maddams et al, 2009) and this number is increasing. Cancer survivors can experience physical, psychological and social consequences as a result of the disease and the treatments received (Jefford et al, 2008; Foster et al, 2009). The effects may be immediate, some of which will resolve and others may persist and become long-term. Late effects can also occur and the interval between the end of treatment and onset can range from a few weeks (e.g. lymphoedema after axillary node removal) to several years (e.g. heart disease following radiotherapy to the chest area). Problems will be individual to each patient due to a unique combination of circumstances including the site and stage of the cancer, the type of treatment(s) given, the age of the patient, genetic factors, concomitant co-morbidities, family and social circumstances, and personality traits.
Type: Journal Article
URI: http://hdl.handle.net/1893/11801
DOI Link: http://dx.doi.org/10.1038/bjc.2011.535
Rights: From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Affiliation: Oxford Brookes University
University of Oxford
Bangor University
University of Chester
South Devon Healthcare Foundation Trust
Cancer Care Research Centre
Macmillan Cancer Support
University of Edinburgh
University of Edinburgh
Bangor University

Files in This Item:
File Description SizeFormat 
Watson et al_BJofC_2012.pdf221.97 kBAdobe PDFView/Open


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.